Author:
Chester Titus,Reynolds Sarah,Thompson Brittany,Durgahee Saleema,Cuthbert Sharon
Subject
Pediatrics, Perinatology and Child Health
Reference11 articles.
1. British Association for Psychopharmacology consensus on the use of psychotropic medication preconception in pregnancy and postpartum 2017;McAllister-Williams;J Psychopharmacol,2017
2. NICE guideline CG192 Antenatal and postnatal mental health: clinical management and service guideline https://www.nice.org.uk/guidance/cg192.
3. FDA Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns: https://www.fda.gov/drugs/drugsafety/ucm243903.htm.
4. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers;Campbell;J Neurol Neurosurg Psychiatr,2014
5. Selective-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn;Chambers;N Engl J Med,2006